Continuous infusion (opioid naive patients): 0.Single-dose (opioid-naive patients): 0.1-0.3 mg single dose, plus an available infusion of naloxone dosage range per manufacturer, is 0.2-1 mg/day because repeated IT injections are not recommended, the alternative route should be used if pain recurs within 24 hours.Continuous infusion: 2-4 mg IV infused over 24 hours.Single-dose: 5-10 mg once daily in the lumbar region.Intravenously (IV) (opioid-naïve patients): 2.5-5 mg every 3-4 hours as needed, infused over 4-5 minutes dose range, 4-10 mg.Subcutaneously/intramuscularly (SC/IM) (opioid-naïve patients): 5-10 mg every 4 hours as needed dose range, 5-20 mg.Opioid-naïve patients: 10-20 mg orally every 4 hours as needed.Opioid-naïve patients: 15-30 mg orally every 4 hours as needed.Assess each patient’s risk before prescribing and monitor all patients regularly for the development of these behaviors or conditions.
Morphine sulfate, suppository: Schedule II Tablet, morphine sulfate immediate release: Schedule II (adult and pediatric) Morphine sulfate, injectable solution: Schedule II (adult and pediatric) Injectable solution, high potency (Infumorph): Schedule II Injectable solution (Duramorph): Schedule II Injectable suspension, extended-release, liposomal (DepoDur): Schedule II 10 mg, 20 mg, 30 mg, 45 mg, 50 mg, 60 mgĬapsule, extended-release (Kadian): Schedule II.15 mg, 30 mg, 60 mg, 100 mg (MorphaBond)Ĭapsule, morphine sulfate extended-release: Schedule II.Tablet, extended release (abuse-deterrent): Schedule II Tablet, extended-release (MS Contin): Schedule II
0 kommentar(er)
